Kairos Pharma, LTD.

Form D Filings

Location
Los Angeles, CA
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001962011
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
1/28/2025 Option to Acquire, Security to be Acquired $3,497,500 $8,750,000 $5,252,500 1/16/2025 1/28/2025 D 000149315225003984
4/27/2023 Debt, Security to be Acquired $675,000 $3,000,000 $2,325,000 6/30/2022 4/26/2023 D 000149315223013724